Glycation-induced inactivation of malate dehydrogenase protection by aspirin and a lens molecular chaperone, α-crystallin

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1315, Issue 3, 1996, Pages 176-184

  Heath, Melanie M ^a   Rixon, Kenneth C ^a   Harding, John J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Aspirin; Chaperone; Glycation; Malate dehydrogenase; Crystallin

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA CRYSTALLIN; CHAPERONE; FRUCTOSE; GLUCOSE; GLUCOSE 6 PHOSPHATE; IBUPROFEN; MALATE DEHYDROGENASE;

ANIMAL TISSUE; ARTICLE; CATTLE; CONTROLLED STUDY; ENZYME INACTIVATION; GLYCATION; HEART; LENS; NONHUMAN; PREVENTION; PRIORITY JOURNAL; SWINE;

ANIMALIA; BOS TAURUS; SUS SCROFA;

EID: 0029968456     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-4439(95)00120-4     Document Type: Article

References (53)

1. Harding, J.J., Egerton, M., Van Heyningen, R. and Harding, R.S. (1993) Br. J. Ophthalmol. 77, 2-6.
2. Stevens, V.J., Rouzer, C.A., Monnier, V.M. and Cerami, A. (1978) Proc. Natl. Acad. Sci. USA 75, 2918-2922.
3. Harding, J.J. (1973) Exp. Eye Res. 17, 377-383.
4. Perry, R.E., Swamy, M.S. and Abraham, B.C. (1987) Exp. Eye Res. 44, 269-282.
5. Ditzel, J., Jaeger, P. and Standl, E. (1978) Metab. Clin. Exp. 27, 929-934.
6. Standl, E. and Kolb, H.J. (1973) Diabetologia 9, 461-466.
7. Shaklai, N. and Garlick, R.L. and Bunn, H.F. (1984) J. Biol. Chem. 259, 3812-3817.
8. Spiro, R.G. (1976) Diabetologia 12, 1-14.
9. Gonzalez, A.M., Sochor, M. and McClean, P. (1980) Biochem. Biophys. Res. Commun. 95, 1173-1179.
10. Beswick, H.T. and Harding, J.J. (1987) Biochem. J. 246, 761-769.
11. Raza, K. and Harding, J.J. (1991) Exp. Eye Res. 52, 205-212.
12. Huby, R. and Harding, J.J. (1988) Exp. Eye Res. 47, 53-59.
13. Ajiboye, R. and Harding, J.J. (1989) Exp. Eye Res. 49, 31-41.
14. Watkins, N.G., Thorpe, S.R. and Baynes, J.W. (1985) J. Biol. Chem. 260, 10629-10636.
15. Zahner, D., Ramirez, R. and Malaisse, W.J. (1990) Diabetes Res. 14, 109-115.
16. Ganea, E. (1988) Revue Roumaine de Biochimie 25, 101-106.
17. Ganea, E. and Harding, J.J. (1995) Eur. J. Biochem. 231, 181-185.
18. Arai, K., Maguchi, S., Fujii, S., Ishibashi, H., Oikawa, K. and Taniguchi, N. (1987) J. Biol. Chem. 262, 16969-16972.
19. Sakurai, T., Matsuyama, M. and Tsuchiya, S. (1987) Chem. Pharm. Bull. (Tokyo) 35, 302-307.
20. Taniguchi, N., Kinoshita, N., Arai, K., Iizuka, S., Usui, M. and Naito, T. (1989) Prog. Clin. Biol. Res. 304, 277-290.
21. Taniguchi, N., Arai, K. and Kinoshita, N. (1989) Methods Enzymol. 179, 570-581.
22. Garner, M.H., Bahador, A. and Sachs, G. (1990) J. Biol. Chem. 265(25), 15058-15066.
23. Harding, J.J. (1991) Cataract: Biochemistry, Epidemiology and Pharmacology, Chapman and Hall, London.
24. Delaye, M. and Tardieu, A. (1983) Nature 302, 415-417.
25. Blakytny, R. and Harding, J.J. (1992) Exp. Eye Res. 54, 509-518.
26. Harding, J.J. and Van Heyningen, R. (1988) Br. J. Ophthalmol. 72, 809-814.
27. Harding, J.J., Egerton, M. and Harding, R.S. (1989) Acta Ophthalmol. 67, 518-524.
28. Crompton, M., Rixon, K.C. and Harding, J.J. (1985) Exp. Eye Res. 40, 297-311.
29. Roberts, K. and Harding, J.J. (1990) Exp. Eye Res. 50, 157-164.
30. Physicians' Health study research group (1988) New England J.Med. 318, 362-364.
31. Horwitz, J. (1992) Proc. Natl. Acad. Sci. USA 89, 10449-10453.
32. Horwitz, J. (1993) Invest. Ophthalmol. Vis. Sci. 34, 10-22.
33. Ingolia, T.D. and Craig, E.A. (1982) Proc. Natl. Acad. Sci. USA 79, 2360-2364.
34. Slingsby, C. and Bateman, O.A. (1990) Exp. Eye Res. 51, 21-26.
35. Harding, J.J. and Dilley, K.J. (1976) Exp. Eye Res. 22, 1-73.
36. Meloun, B., Moravek, L. and Kostka, V. (1975) FEBS Lett. 58, 134-137.
37. Brown, J.R. and Shockley, P. (1982) in Lipid-Protein Interactions, Vol. 1, pp. 25-68. Wiley, New York.
38. Nisbet, A.D., Saundry, R.H., Moir, A.J.G., Fothergill, L.A., Fothergill, J.E. (1981) Eur. J. Biochem. 115, 335-345.
39. Canfield, R.E. (1963) J. Biol. Chem. 238, 2698-2707.
40. Pennington, J. and Harding, J.J. (1994) Biochem. Biophys. Acta 1226, 163-167.
41. Harding, J.J. (1985) Adv. Protein Chem. 37, 247-334.
42. Jedziniak, J.A., Chylack, L.T., Jr., Cheng, H.-M., Gillis, M.K., Klaustian, A.A. and Tung W.H. Tung, W.H. (1981) Invest. Ophthalmol. Vis. Sci. 20, 314-326.
43. Bunn, H.F. and Higgins, P.J. (1981) Science 213, 222-224.
44. Szwergold, B.S., Kappler, F. and Brown, T.R. (1990) Science 247, 451-454.
45. Birktoft, J.J., Rhodes, G. and Banaszac, L.J. (1989) Biochemistry 28, 6065-6081.
46. Nacharaju, P. and Acharya, A.S. (1992) Biochemistry 31, 12673-12679.
47. Iberg, N. and Fluckiger, R. (1986) J. Biol. Chem. 261, 13542-13545.
48. Blakytny, R. and Harding, J.J. (1992) Biochem. J. 288, 303-307.
49. Shyadehi, A.Z. and Harding, J.J. (1991) Biochem. Pharmacol. 42, 2077-2084.
50. Van der Ouderaa, F.J., De Jong, W.W. and Bloemendal, H. (1973) Eur. J. Biochem. 39, 207-222.
51. Van der Ouderaa, F.J., De Jong, W.W., Hilderink, A. and Bloemendal, H. (1974) Eur. J. Biochem. 49, 157-168.
52. Gething, M.-J. and Sambrook, J. (1992) Nature 355, 33-45.
53. Hartl, F.-U., Hlodan, R. and Langer, T. (1994) Trends Biochem. Sci. 19, 20-25.